Objectives: To verify the effectiveness of support power of underwear (the shaper) to elevate bladder neck and to reduce symptoms of stress urinary incontinence (SUI).
Introduction
Pelvic relaxation results in decreased support for the urinary tract and a descent of the bladder neck, leading to stress urinary incontinence (SUI). Urinary incontinence (UI) is reported to be experienced by 29% of healthy women in age group 30-60, and 78% of such cases are attributed to SUI 1 . Stress urinary incontinence is often considered embarrassing in women, and it has a negative impact on their quality of life (QOL) 2 . Many women with SUI try to control themselves by using pads and going to a toilet regularly 3 . Although SUI can be treated, most women with SUI do not consider treating it. On the other hand, some women have mild SUI and do not feel the necessity of treatment, because of its little influence on their daily life 4 . However, mild SUI may become aggravated later by risk factors such as pregnancy, delivery, aging, menopause, and obesity 5 . Therefore, early treatment and prevention are required.
We are developing a new treatment for women with mild SUI, in which SUI is treated using an open-configuration magnetic resonance system GE SIGNA SP/2, 0.5 tesla (Open MR), which can be performed in a sitting or standing posture. In collaboration with the manufacturer, Wacoal Corporation (Kyoto, Japan), we are investigating the possibility of elevation in the bladder neck caused due to the use of the underwear, and also the validity of the product supportive underwear (SLIM-up-Pant with Style Science ® ; the shaper). The surgical treatment for SUI involves suspending the bladder neck or supporting the lower urinary tract by a sling 6 . This indicates that SUI may improve by elevating the bladder neck and supporting it with a support from the outside by underwear. If SUI could be reduced 4 simply by wearing underwear, which is easy to continue, it would be a good treatment for SUI. Therefore, in this study, we examined two research questions:
(1) Is the bladder neck elevated due to the use of the shaper?
(2) Does SUI reduce during the period of 12 weeks of use of the shaper?
Methods

Study design and setting
This was a single-arm pilot study, interventional clinical trial based on a before-after design, aimed to verify the effectiveness of the shaper to elevate the bladder neck and reduce the symptoms of UI in parous women. This study was done from January 2009 to August 2010.
Ethical considerations
This study was approved by the ethical review board of Shiga University of Medical Science (20-69) and by the ethical review board of Kobe University Graduate School of Health Sciences (63), and it conforms to the provisions of the Declaration of Helsinki. All participants gave a signed informed consent.
Participants
The participants were parous women with SUI, as defined by the International Continence Society (ICS) 7 . The inclusion criteria for the participants were as follows: age 20-65 years, SUI or mixed urinary incontinence (MUI) with urinary leakage episodes at least once a week, and possibility of wearing the shaper for 12 weeks. The bladder neck position was assessed based on sagittal T 1 -weighted spoiled gradient-echo images of the pelvis, using a surface coil in a toilet seat and an Open MR taken in a sitting posture, because evaluation of the pelvic organ in SUI is better if done in a posture subject to vertical gravity 9 .
Because MRI was performed without using any contrast agent, the participants were MRI of the pelvis was performed in three motions: "at rest", "at pelvic floor muscle (PFM)
contraction", and "at pelvic strain". The order was "at rest", "at PFM contraction", "at rest", "at pelvic strain". This was repeated twice, and the imaging time was 9 sec/motion. Before MRI, the participants were instructed by the researcher using the explanator y leaflet about "at PFM contraction" and "at pelvic strain". MRI was completed in 10 min.
The bladder neck position was analyzed on the mid-sagittal images. The pubococcygeal line (PC line) was used to represent the normal location of the pelvic floor 10 . The PC line was used as the reference point (0 mm), the perpendicular distance up to the bladder neck was measured (in mm). Accordingly, the bladder neck position was shown as higher (+) or lower (−) with respect to the PC line. For each image, measurements were performed twice, and the mean values were calculated.
Symptoms of UI
Four outcome measures were used evaluate the symptoms of UI: the 1-h pad test, the Japanese version of the International Consultation Incontinence Questionnaire-Short Form (ICIQ-SF) 11 , the number of incontinence episodes per week, and the frequency of voiding per day. The 1-h pad test was performed according to the recommendations by the ICS 12 , to evaluate severity and objective symptoms of UI. Higher ICIQ-SF scores indicate a greater severity of UI symptoms and a larger impact on the QOL. Since the Japanese version of the ICIQ-SF includes a question about the causes of urinary leakage, which was not included in the score, this question was used to differentiate between SUI and MUI in this study. The incontinence episodes and frequency of voiding were recorded daily by the participants in an incontinence diary. In this diary, free space was included for participants to enter changes, comments, etc. every day. Figure 1 shows the flow diagram of the study. First, for research question (1), the bladder neck position in a sitting posture was recorded using an Open MR, and it was compared between participants without and with the shaper. The interval between each MRI was about 5 min. Second, for research question (2), the participants wore the shaper during daytime and continued usual activities for 12 weeks, followed by one week during which they did not wear the shaper. This helped to verify whether UI symptoms recur immediately if the use of the shaper was stopped for one week, even if the UI were improved earlier. During the study period, the participants counted the number of steps using a pedometer.
Procedures
At the end of this study, the participants were asked whether they wanted to continue 8 wearing the shaper after this study, and were requested to grade how comfortable they were by wearing the shaper into five grades from "very good" to "very poor".
Statistical analysis
Statistical analyses were carried out using the software SPSS Version 19.0 for Windows (IBM Japan). Continuous data were checked for normality by Shapiro-Wilk tests.
Subgroup analyses were performed using various tests as indicated in the Tables: Wilcoxon   signed- 
Results
Study overview
This was a single-arm pilot study conducted on Japanese women with SUI, implemented as depicted in Figure 1 . Fifty women who wished to participate were telephonically screened, 45 of them participated and 41 completed this study (dropout rate: 8.9%). The characteristics of participants at baseline are shown in Table 1 . Severity of UI was graded based on the standard of ICS in the 1-h pad test of baseline. Although there were 16 women (35.6%) who had undergone the pelvic floor muscle training before, none of them received the specialist's instruction or were continuing it. Four women who dropped out had SUI, including two with slight and two with moderate UI.
Elevation of the bladder neck from wearing the shaper-research question (1)
In "at rest" position, the bladder neck in women wearing the shaper was significantly higher than those without (P < 0.008). The extent of elevation was 11.5 mm (median; 95% CI, 10.0-12.9; Table 2 ). Moreover, wearing the shaper elevated the bladder neck in all 45
women (100%). Likewise, the bladder neck position was significantly different between with and without the shaper for the other two motions, "at PFM contraction" and "at pelvic strain" (P < 0.008). Interestingly, the bladder neck position showed no difference (difference, 0.5 mm; 95% CI, −2.1 to 3.3; P > 0.008) between "at rest" without the shaper (median, 0.0 mm) and "at pelvic strain" with the shaper (median, 0.9 mm) (A vs. F). In other words, the results showed that the bladder neck position on wearing the shaper is maintained at the same height as "at rest" without the shaper, if the abdominal pressure is added. In addition, the bladder neck position "at rest" while wearing the shaper (median, 11.7 mm) was significantly higher than the position "at PFM contraction" (median, 6.9 mm) without the shaper (difference, 4.4 mm; 95% CI, 1.8-6.6; P < 0.008) (B vs. D). In other words, the results showed that the bladder neck position was elevated to a higher level than by performing voluntary PFM contraction by wearing the shaper. Figure 2 shows an example of MRI.
Decrease in symptoms of UI by wearing the shaper-research question (2)
Outcome measures were compared over the entire study period (Table 3) . Compared to baseline, the 1-h pad test, the ICIQ-SF and the number of incontinence episodes per week were significantly decreased after 6 weeks of wearing the shaper (P < 0.003). In addition, compared to baseline, at 12 weeks the 1-h pad test and the ICIQ-SF indicated a further decrease (P < 0.003) and the frequency of voiding per day was also decreased significantly (P < 0.016). Moreover, the bladder neck position without the shaper was more elevated than baseline after 12 weeks (difference, 4.7 mm; 95% CI, 2.8-6.6; P < 0.003). Next, compared to 12 weeks, there was no significant change in any of the four outcome measures related to UI, and no change in the bladder neck position after the one week follow-up, during which the participants did not wear the shaper (difference, 1.7 mm; 95% CI, −0.5 to 4.3; P > 0.016). In other words, these results showed that wearing the shaper in daytime for 12 weeks reduced symptoms of UI, and this effect was sustained for at least one week after stopping wearing the shaper.
The symptoms of UI decreased or disappeared after 12 weeks in 35 of 41 women (85.4%). In addition, both MUI as well as SUI improved (Table 4) . Moreover, this improvement did not relate to the severity of the UI symptoms; UI symptoms disappeared in two of three women with moderate UI, and in all three women with severe UI. The average steps as counted by pedometer for 12 weeks was 8713 steps/day (25th-75th percentile, 6650-10 247; n = 41). The number of steps did not correlate with the reduction of UI and elevation of the bladder neck position after 12 weeks.
Safety and adherence of wearing the shaper
No participant reported side-effects such as skin trouble or changes in voiding function on wearing the shaper for 12 weeks. These were confirmed from the notes of the participants in the free space of the incontinence diary, and by oral questioning. In addition, when inquired at the end of the study, all participants wished to continue wearing the shaper even after the study. Further, all participants graded the comfort of wearing the shaper as "good" or "very good".
Discussion
This study verified the effectiveness of the shaper to elevate the bladder neck and to reduce the symptoms of UI in parous women. The major findings of this study revealed that wearing the shaper elevated the bladder neck in all participants; that even on adding an abdominal pressure, the bladder neck was maintained at the same position as that at rest without wearing the shaper; and that the bladder neck position was higher than that at voluntary PFM contractions without wearing the shaper. In addition, this study showed that wearing the shaper for 12 weeks led to significant improvements in symptoms of UI, and these symptoms did not recur immediately even when the participants stopped wearing the shaper for one week. The effect was found to be valid not only in women with SUI but also in those with MUI. Wearing the shaper was also found to be effective even against severe UI, and 85.4% of the participants showed an improvement in the symptoms. The strengths of this study include the low dropout rate, high adherence rate, and the fact that the assessment of the bladder neck position was conducted using MRI in a sitting posture, which was close to the posture subject to vertical gravity in which urinary leakage was likely to occur.
By wearing the shaper, since all participants accepted elevation of the bladder neck, the 12 shaper could potentially have an effect of reducing the symptoms of SUI in all participants.
The participants included in this study showed a large range of age, and time since last delivery. However, since the effect of wearing the shaper to elevate the bladder neck was large, it is thought that these two variables did not affect the outcome.
In a previous study, Fielding and his group 13 reported that the bladder neck position of eight women with SUI (years of age; 45-69) was an average of 22 mm below the PC line in sitting posture. The discrepancy in this and our study may be attributed to the difference s in sample size and characteristics of the study population. Although the normal position of the bladder neck was not well-defined for the participants in this study, urinary leakage did not occur "at rest", but occurred "at pelvic strain" in women with SUI, therefore it was based on position "at rest". When wearing the shaper, the bladder neck position "at pelvic strain" was maintained at the same position as "at rest" without the shaper, thus it could have prevented the urinary leakage. In addition, the bladder neck was open "at pelvic strain" without wearing the shaper, but it was flat "at pelvic strain" with wearing the shaper. Miller and his group 14 reported that no urinary leakage occurs when a contraction of the PFM is performed at the moment of a sneezing or a cough (the Knack maneuver). In this study, simply wearing the shaper allowed the bladder neck to reach an elevation higher than that "at PFM contraction" without wearing the shaper.
The reasons why the shaper could have led to the elevation of the bladder neck could be as follows: it did not have strong support power for the abdomen, and it led to the elevation of not only the bladder neck but also the fundus of the bladder, suggesting that it was 13 effective to lift the gluteal region from behind. According to the integral theory of female UI 15 , the normal pelvic floor function is considered analogous to a suspension bridge, and structure and function of pelvic floor are related mutually. The supportive power of underwear is believed to complement the strength of internal muscles, fascia and ligaments, and keep the structure of the pelvic floor in a balanced state. We estimate that this balanced state will be a mechanism effective in improving UI by the shaper.
After wearing the shaper for 12 weeks, the bladder neck position was found to be elevated even without wearing the shaper, and the symptoms of UI did not immediately recur after the use of the shaper was discontinued. Braekken and his group 16 previously reported having achieved a 4.3 mm (95% CI, 2.1-6.5) elevation of the position of the bladder through 6 months of PFM training. The shaper used in this study is designed to strengthen the muscles of buttocks. Possibly, wearing the shaper for 12 weeks might have influenced not only these muscles, but also the muscles of PFM. This might be associated with the fact that the shape of the bladder "at rest" while wearing the shaper resembled that "at PFM contraction" without the shaper, and also with the fact that merely by wearing the shaper, the bladder neck position can be elevated higher than "at PFM contraction" without the shaper. However, although the patent of buttocks muscles strengthening by wearing the shaper and walking was acquired, there is no report that shows the scientific evidence of i t.
In addition, the number of steps did not correlate with the reduction of UI and elevation of the bladder neck position after 12 weeks.
In this study, we were not able to show clearly why wearing the shaper could have led to 14 the elevation of the bladder neck, and which parts of the support power of the shaper led to the elevation of the bladder neck, which was more effective in reducing the symptoms of UI between the elevation of the bladder neck or the PFM strengthening. It is important to elucidate these mechanisms in the future.
The limitations of this study were that it was the first trial, and it was not a randomized controlled trial but a before-after design without any control groups. Therefore, the result of this study cannot deny the placebo effect. Moreover, MRIs were analyzed by one researcher who was not blinded. In addition, the changes in the strength of PFM were not directly evaluated. However, the effect of elevating the bladder neck and in reducing symptoms of UI was enough to cover these imperfections.
In the participants of this study, although urination was stopped for an hour before MRI, bladder volume was not fixed. However, since there was no clear difference in the bladder volume of the same participant, probably, it has very little influence on the result.
The treatment of SUI often imposes a number of burdens on women. Although PFM training can achieve a 35-80% improvement rate 17 , adherence decreases in the long-term 18 .
In addition, since 30% of women cannot contract their PFM correctly, PFM training is ineffective in such women 19 . For biofeedback and functional electrical stimulation, regular hospital visits are necessary. In contrast, wearing the shaper is easy, and does not interfere with daily life. The improvement rate of the symptoms of UI by wearing the shaper was 85.4%, and it was effective not only in mild SUI, but also in MUI and severe UI. Wearing the shaper may expand the possibility of the treatment of UI.
15
In conclusion, wearing the shaper elevated the bladder neck in all participants, and use of the shaper for 12 weeks led to significant improvements in symptoms of UI. In addition, symptoms of UI did not recur immediately even when the participants stopped wearing the shaper. Although a randomized controlled trial, short or long-term evaluation, and the elucidation of mechanism to elevate the bladder neck and to reduce the symptoms of UI will be required, this pilot study has demonstrated that the use of underwear might be a promising treatment option for management of UI symptoms. 
